Metabolic demand reduction

Metabolic demand reduction is a physiological strategy and clinical objective rather than a discrete molecular target, such as a receptor or enzyme. It refers to the process of decreasing the energy and oxygen requirements of tissues—most commonly the heart—to prevent cellular damage and ischemia when oxygen supply is compromised (StatPearls, NBK545277). In clinical practice, this goal is achieved by pharmacologically modulating various proteins, such as beta-adrenergic receptors or calcium channels, to lower heart rate, contractility, and ventricular wall tension (AHA, 2023). While critical in the management of cardiovascular diseases like angina and heart failure, the term describes a broad therapeutic outcome rather than a single targetable molecule. Consequently, drugs that achieve metabolic demand reduction do so through diverse mechanisms of action depending on their specific molecular targets (PubMed, 11410402).

Other names

Myocardial oxygen demand reductionMetabolic suppressionEnergy demand reductionMVO2 reduction

Reduction of cellular workload and oxygen consumption through negative chronotropic, inotropic, and dromotropic effects, or by shifting metabolic substrates to improve energy efficiency.